• Home
  • A-B index
  • Pharmacological Index
  • Drug Classes
  • Active Ingredients
  • Companies
  • News
  • Klaridex
    / Dexcel


    Active Ingredient

    Status in Israel
    RX

    Presentation and Status in Health Basket

    Presentation Basket Yarpa Pharmasoft

    Caplets

    14 X 250 mg

    not in the basket chart 22667 11014

    Related information


    Dosage

    For additional information, please contact the license holder.


    Indications

    Klaridex is indicated in the treatment of infections caused by one or more susceptible organisms. Indications include: Lower respiratory tract infections, for example, acute and chronic bronchitis and pneumonia. Upper respiratory tract infections, for example, sinusitis and pharyngitis. Klaridex is appropriate for initial therapy in community acquired respiratory infections and has been shown to be active in vitro against common and atypical respiratory pathogens as listed in the microbiology section. Klaridex is also indicated in skin and soft tissue infections of mild to moderate severity. Klaridex is also indicated in combination with proton pump inhibitor for the eradication of H. Pylori in patients with proven duodenal ulcer. Treatment of Mycobacterium Avium Complex infection in AIDS patients.


    Contra-Indications

    Hypersensitivity (allergic) to the active ingredient or to any of the other ingredients of this medicine or to another antibiotic of the macrolide group such as: erythromycin or azithromycin. Clarithromycin should not be used in patients who suffered from Jaundice or another hepatic problem followed the use of clarithromycin in the past. Concomitant administration of clarithromycin and any of the following drugs is contraindicated: Astemizole or terfenadine, cisapride, pimozide– the combination with these medicines may cause heart rate disorders. Eletriptan, ergotamine or dihydroergtamine or ergotamine inhalers. Eplerenone (for the treatment of heart failure). Ivabradine, ranolazine or ticagrlor. Medicines of the statins group such as: lovastatin, simvastatin, pravastatin, atorvastatin or rosuvastatin. Clarithromycin should not be given to patients with hypokalaemia. Patient who suffer from liver and/or kidney problems. Clarithromycin should not be given to patients who suffers or has suffered in the past from heart rate problems (such as ventricular arrhythmias including “Torsades de pointes”) or an ECG abnormality called “long QT syndrome”.


    Special Precautions

    For additional information, please contact the license holder.


    Side Effects

    For additional information, please contact the license holder.


    Drug interactions

    Astemizole, terfenadine, cisapride, pimozide, ergotamine, dihydroergotamine, colchicine.
    See literature for full details.


    Pregnancy and Lactation

    For additional information, please contact the license holder.


    Overdose

    For additional information, please contact the license holder.


    Manufacturer
    Dexcel Ltd.
    Licence holder
    CLOSE